Item
L-Arginine-A-Ketoglutarate 2:1 (11003)
L-Arginine 65.5-69.0%
α-Ketoglutarate 26.5-29.0
Nutrient / Vitamin
Attributes
- Gluten-free
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| Jing Jing Pharmaceutical Co., Ltd | 88#, Jingyi Road, DaCaoZhuang Industrial Zone, Ningjin County Xingtai City, Hebei Province N/A CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Safety Data Sheet (SDS) | Jing Jing Pharmaceutical Co., Ltd | 11003 AAKG 2-1 - Jing Jing - SDS_2020.pdf | 9/28/2020 | 9/28/2023 |
| GFSI Certificate | Jing Jing Pharmaceutical Co., Ltd | 3rd Party Food Safety Certificate - 2025-03-14T101838.780.pdf | 10/18/2023 | 9/24/2026 |
| Food Defense Plan Statement | Jing Jing Pharmaceutical Co., Ltd | 3rd party-Haccp doc - Prinova.pdf | 3/14/2025 | 3/14/2027 |
| HACCP Plan (Facility) | Jing Jing Pharmaceutical Co., Ltd | 3rd party-Haccp doc - Prinova.pdf | 3/14/2025 | 3/14/2027 |
| Label Sample | Jing Jing Pharmaceutical Co., Ltd | AAKG 2-1 Jing Jing (50340) - Packaging declaration (cn) amended(1).pdf | 6/3/2021 | 6/3/2024 |
| Gluten | Jing Jing Pharmaceutical Co., Ltd | AAKG 2-1 Jing Jing 50340 - Allergen Status CN.pdf | 6/3/2021 | 6/3/2022 |
| GMO | Jing Jing Pharmaceutical Co., Ltd | AAKG 2-1 Jing Jing 50340 - GMO Status 1.pdf | 6/3/2021 | 6/3/2023 |
| Lot Code | Jing Jing Pharmaceutical Co., Ltd | AAKG 2-1 Jing Jing 50340 - Packagingdeclarationcnamended1 1.pdf | 6/3/2020 | 6/3/2023 |
| BSE - TSE | Jing Jing Pharmaceutical Co., Ltd | AAKG 2-1 Jing Jing 50340 - Regulatory Information Sheet CN.pdf | 6/3/2021 | 6/2/2024 |
| Allergens | Jing Jing Pharmaceutical Co., Ltd | Allergens.pdf | 6/7/2024 | 6/7/2026 |
| WADA/NSF/NFL Statement | Jing Jing Pharmaceutical Co., Ltd | Banned Substance (90).pdf | 6/8/2023 | 6/7/2025 |
| Residual Statement | Jing Jing Pharmaceutical Co., Ltd | Contaminants and Impurities - 2023-08-02T110255.052.pdf | 6/8/2023 | 6/7/2024 |
| Country of Origin | Jing Jing Pharmaceutical Co., Ltd | Country of Origin.pdf | 12/5/2022 | 12/4/2025 |
| Dietary Supplement Questionnaire | Jing Jing Pharmaceutical Co., Ltd | Dietary Supplement Questionnaire.pdf | 6/1/2022 | 6/1/2023 |
| HACCP Process Flow Diagram | Jing Jing Pharmaceutical Co., Ltd | Flow Chart - 2023-08-02T111112.613.pdf | 6/8/2023 | 6/7/2025 |
| Letter of Guarantee | Jing Jing Pharmaceutical Co., Ltd | GUARANTEE Nutrivo.pdf | 3/14/2025 | 3/14/2027 |
| Item Questionnaire | Jing Jing Pharmaceutical Co., Ltd | Item Questionnaire.pdf | 6/1/2022 | 5/31/2025 |
| CoA Sample | Jing Jing Pharmaceutical Co., Ltd | NotApplicable_COASample.pdf | 5/25/2021 | 5/25/2023 |
| Nutrition | Jing Jing Pharmaceutical Co., Ltd | Nutrition.pdf | 8/17/2023 | 8/16/2026 |
| California Prop. 65 | Jing Jing Pharmaceutical Co., Ltd | Product Data Sheet - 2023-08-02T110420.859.pdf | 6/8/2023 | 6/7/2025 |
| Ingredient Statement | Jing Jing Pharmaceutical Co., Ltd | Product Data Sheet - 2023-08-02T110420.859.pdf | 6/3/2023 | 6/2/2024 |
| Suitability Requirements | Jing Jing Pharmaceutical Co., Ltd | Suitability Requirements.pdf | 11/15/2019 | 11/14/2022 |
